Page last updated: 2024-08-26

imipenem, anhydrous and Arthropathies

imipenem, anhydrous has been researched along with Arthropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anoushiravani, A; Farsad, K; Gabr, A; Horikawa, M; Jahangiri, Y; Kumagai, K; Li, J; Uchida, B; Yamada, K1
Dretler, RH; Job, ML1

Other Studies

2 other study(ies) available for imipenem, anhydrous and Arthropathies

ArticleYear
Embolic Characteristics of Imipenem-Cilastatin Particles in Vitro and in Vivo: Implications for Transarterial Embolization in Joint Arthropathies.
    Journal of vascular and interventional radiology : JVIR, 2021, Volume: 32, Issue:7

    Topics: Animals; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Imipenem; Joint Diseases; Male; Rats; Rats, Sprague-Dawley

2021
Seizure activity with imipenem therapy: incidence and risk factors.
    DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:5

    Topics: Aged; Aged, 80 and over; Bacterial Infections; Humans; Imipenem; Joint Diseases; Knee Joint; Male; Pneumonia; Risk Factors; Seizures

1990